TransMedics Group vs UFP Technologies
TransMedics Group reported revenue of $606 million in fiscal 2025, about the same as UFP Technologies' $603 million in fiscal 2025. TransMedics Group's revenue grew 37.1% in its latest year, and UFP Technologies' grew 19.5%. TransMedics Group had an operating margin of 17.9%, against 15.3% at UFP Technologies.
Side by side
| TransMedics Group | UFP Technologies | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $606M | $603M |
| Revenue growth | 37.1% | 19.5% |
| Revenue growth a year, last 5 years | 88.3% | 27.4% |
| Gross margin | 59.9% | 28.3% |
| Operating margin | 17.9% | 15.3% |
| Net margin | 31.4% | 11.3% |
| Free cash flow | $134M | — |
| Free cash flow margin | 22.1% | — |
| Return on capital | 27.5% | 14.4% |
| Net debt to EBITDA | −0.2x | 1.0x |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 15.1% | 0.2% |
| Last close | $88.24 | $303.47 |
| P/E at the last close | 24.1× | 30.9× |
| Insider trades, last 12 months | bought $1.1 million, sold $4.3 million | sold $13.6 million |
| Piotroski F-score | 7 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
TransMedics GroupUFP Technologies
Operating margin
Percent of revenue
TransMedics GroupUFP Technologies
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
TransMedics GroupUFP Technologies
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the TransMedics Group and UFP Technologies pages.